Resources Resource Type All Resources Publication (23) Year All Years 2024 (3) 2021 (1) 2020 (4) 2019 (1) 2018 (3) 2014 (3) 2011 (3) 2009 (1) 2007 (1) 2006 (1) 2005 (2) 2003 (1) Search Found 24 Results January 4, 2024 A phase 2 trial of CD24Fc for prevention of graft-versus-host disease Read more August 22, 2022 CD24-Siglec axis is an innate immune checkpoint against metaflammation and metabolic disorder Read more July 15, 2022 CD24Fc ameliorates immune-related adverse events while preserving anti-tumor therapeutic effect Read more February 9, 2021 Dual Targeting Oncoproteins MYC and HIF1α Regresses Tumor Growth of Lung Cancer and Lymphoma. Read more July 30, 2020 Liposomal formulation of HIF-1α inhibitor echinomycin eliminates established metastases of triple-negative breast cancer. Read more April 1, 2020 Therapeutic targeting of TP53-mutated acute myeloid leukemia by inhibiting HIF-1α with echinomycin. Read more 1234»
